CD98 is overexpressed in several hematological malignancies; in AML, CD98 promotes the propagation and lethality of AML by promoting the interaction of leukemic cells with their microenvironment and maintaining LSCs [63] and contributing to the growth of AML and the survival of LSCs [63]. The gene discussed is SLC3A2; the disease is hematologic disorder.